|
RELATED
|
|
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of...
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of...
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The...
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. The...
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.
Richard Alleyne in London July 3, 2009 A PIONEERING prostate cancer treatment is more successful than radiotherapy or surgery, British scientists say. Traditional therapies are invasive and require overnight stays in hospital,...
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.
Making a huge breakthrough in cancer research, scientists have developed a revolutionary non-invasive treatment that uses sound waves to blast prostate cancer. In a trial at University College Hospital and the private Princess...
ScienceDaily (July 2, 2009) — Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of...
Pharmaceuticals, Ambulatory Health Care, Cancer by Body Location, General Hospitals, Cancer Therapy, Scientific Discoveries, Male Health, Hospital Care, Health Care, Cancer Surgery, Hormone Therapy, Cancers, Prostate Cancer, Surgery, Medicines & Remedies, Medical Research, Patients
